Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

KNOREX Receives NYSE American Notice Regarding Continued Listing Standards

$KNRXPress releaseAug 26, 2026, 5:00 PM ETRead the release

KNOREX received a notice from NYSE American stating it is not in compliance with continued listing standards due to a stockholders' deficit of $6.5 million and net losses in each of the last four fiscal years. The company intends to submit a plan to regain compliance by September 20, 2026, with a target cure date of February 21, 2028.

Key figures

Compliance deadline
February 21, 2028
Required equity low
$2.0 million
Required equity high
$4.0 million
Stockholders deficit
$6.5 million
Plan submission deadline
September 20, 2026

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    KNRX: KNOREX Receives NYSE American Notice Regarding Continued Listing Standards — AI Analysis | Signal8